The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
Abstract
Purpose: Analysis of circulating DNA in plasma can provide a useful marker for earlier lung cancer detection. This study was designed to assess the sensitivity and specificity of a quantitative molecular assay of circulating DNA to identify patients with lung cancer and monitor their disease. Materials and Methods: The amount of plasma DNA was determined through the use of real-time quantitative polymerase chain reaction (PCR) amplification of the human telomerase reverse transcriptase gene (hTERT) in 100 non–small-cell lung cancer patients and 100 age-, sex-, and smoking-matched controls. Screening performance of the assay was calculated through the receiver operating characteristic (ROC) curve. Odds ratios were calculated using conditional logistic regression analysis. Results: Median concentration of circulating plasma DNA in patients was almost eight times the value detected incontrols (24.3 v 3.1 ng/mL). The area under the ROC curve was 0.94 (95% CI, 0.907 to 0.973). Plasma DNA was a strong risk factor for lung cancer; concentrations in the upper tertile were associated with an 85-fold higher risk than were those in the lowest tertile. Conclusion: This study shows that higher levels of free circulating DNA can be detected in patients with lung cancer compared with disease-free heavy smokers by a PCR assay, and suggests a new, noninvasive approach for early detection of lung cancer. Levels of plasma DNA could also identify higher-risk individuals for lung cancer screening and chemoprevention trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Holland, P. M., Abramson, R. D., Watson, R., & Gelfand, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7276 · Cited by 2,693
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
(1977) · PubMed · Cited by 1,801
Lo, Y. M. D., Tein, M. S. C., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., Wainscoat, J. S., Johnson, P. J., Chang, A. M. Z., & Hjelm, N. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301800 · Cited by 1,653
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Predicting lung cancer by detecting aberrant promoter methylation in sputum.
Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000) · PubMed · Cited by 816
About the possible origin and mechanism of circulating DNA
Stroun, M., Lyautey, J., Lederrey, C., Olson-Sand, A., & Anker, P. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00665-9 · Cited by 740
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Mortality from smoking worldwide
Peto, R., Lopez, A. D., Boreham, J., Thun, M., Heath, C., & Doll, R. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011519 · Cited by 638
Molecular Damage in the Bronchial Epithelium of Current and Former Smokers
Wistuba, I. I., Virmani, A. K., Gazdar, A. F., Lam, S., LeRiche, J., Behrens, C., Fong, K. M., Samet, J. M., Srivastava, S., & Minna, J. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1366 · Cited by 485
Clonal Genetic Alterations in the Lungs of Current and Former Smokers
Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Broxson, A., Khuri, F. R., Hong, W. K., Lee, J. J., Yu, R., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.857 · Cited by 453
Microsatellite alterations as clonal markers for the detection of human cancer.
Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., & Sidransky, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9871 · Cited by 447
Shapiro, B., Chakrabarty, M., Cohn, E. M., & Leon, S. A. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11<2116::aid-cncr2820511127>3.0.co;2-s · Cited by 403
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92208-x · Cited by 398
Lo, Y. M. D., Chan, L. Y. S., Chan, A. T. �., Leung, S. F., Lo, K. W., Zhang, J., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 390
Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 380
Self-citationAhrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., & Rilke, F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2858 · Cited by 302
Self-citationSundaresan, V., Ganly, P. S., Hasleton, P. S., Rudd, R., Sinha, G., Bleehen, N. M., & Rabbitts, P. H. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90371-4 · Cited by 257
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi, G., Miozzo, M. R., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Porta, G., & Pierotti, M. A. (1992) · PubMed · Cited by 250
Self-citationAngiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
Keith, R. L., Miller, Y. E., Gemmill, R. M., Drabkin, H. A., Dempsey, E. C., Kennedy, T. C., Prindiville, S. A., & Franklin, W. A. (2000) · PubMed · Cited by 199
Kersting, M., Friedl, C., Kraus, A., Behn, M., Pankow, W., & Schuermann, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3221 · Cited by 181
Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung
Pelosi, G., Fraggetta, F., Pasini, F., Maisonneuve, P., Sonzogni, A., Iannucci, A., Terzi, A., Bresaola, E., Valduga, F., Lupo, C., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200103000-00011 · Cited by 175
Self-citationSoria, J., Rodriguez, M., Liu, D. D., Lee, J. J., Hong, W. K., & Mao, L. (2002) · PubMed · Cited by 138
Sozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P. G., Pierotti, M. A., & Pastorino, U. (1999) · PubMed · Cited by 138
Self-citationAssessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer
Chang, H. W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.22.1697 · Cited by 132
Wang, L., Soria, J., Kemp, B. L., Liu, D. D., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 95
Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer
Allan, J. M., Hardie, L. J., Briggs, J., Davidson, L. A., Watson, J. P., Pearson, S. B., Muers, M. F., & Wild, C. P. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1058>3.0.co;2-e · Cited by 58
Cited by
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Cancer biomarker detection: recent achievements and challenges
Wu, L., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00370e · Cited by 1,214
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Metadata
- Authors
- Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., Pierotti, M. A., & Pastorino, U.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-11-01
- Volume
- 21
- Issue
- 21
- Pages
- 3902-3908
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2120649999
- Cited by
- 552
- References
- 33
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.